Yoon In-ho, Executive Director of Dongwha Pharm

Yoon In-ho, Executive Director of Dongwha Pharm

View original image

[Asia Economy Reporter Chunhee Lee] Yoon In-ho, Executive Director and fourth-generation member of Dongwha Pharm, has been promoted to Vice President and will serve as the company's Chief Operating Officer (COO).


Dongwha Pharm announced on the 21st that Executive Director Yoon has been promoted to Vice President and appointed as COO in the recent regular executive personnel reshuffle. The effective date of the appointment is next month, the 1st.


The newly appointed Vice President Yoon graduated from the University of Wisconsin-Madison with a degree in Economics and joined Dongwha Pharm as a manager in 2013. He was promoted to Managing Director in 2018 and joined the board of directors as a registered executive in March 2019. With this promotion to COO, he is expected to take responsibility for company operations.


With this, the fourth-generation management of Dongwha Pharm is expected to be fully launched centered on the new Vice President Yoon. Current Dongwha Pharm Chairman Yoon Do-jun has one son and one daughter with Managing Director Yoon Hyun-kyung and the new Vice President Yoon.


Additionally, in this executive reshuffle, Dongwha Pharm appointed Managing Director Kim Dae-hyun as Head of Marketing, Deputy Managing Director Sung Kyung-soo as Head of Future Strategy, and Associate Director Yoo Jung-hoon as Head of Management.



Dongwha Pharm was established in 1897 under the name "Donghwa Pharmacy" by Min Byung-ho, a former royal guard and inventor of "Hwalmyungsu," and his son Min Kang. It was converted into a corporation in 1930, and in 1937, Yoon Chang-sik, known as the "second founder," acquired the company. The company name was changed to "Dongwha Pharm" in 1962. The newly appointed Vice President Yoon is the great-grandson of Yoon Chang-sik, the second founder.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing